Rimonabant

CAT: 0931-T1519L-01Size: 1 mL - 10 mM (in DMSO)Dry Ice: NoHazardous: No
CAT#:0931-T1519L-01Size:1 mL - 10 mM (in DMSO)
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
168273-06-1
Target
Acyltransferase|||Antibacterial|||Cannabinoid Receptor
Related Pathways
Microbiology/Virology|||GPCR/G Protein|||Metabolism
Purity
0.9991
Bioactivity
Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States.
Smiles
Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1
Molecular Formula
C22H21Cl3N4O
Molecular Weight
463.79
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName

Alternative Products

CatalogName
MBS3602569-01Rimonabant
GX9120-10mgRimonabant base
A3766-1000Rimonabant hydrochloride
HY-14137-01Rimonabant (Hydrochloride)
MBS386208-01Rimonabant (SR141716)

Popular Products